Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Needham raised its price target on Glaukos to $127 from $125 while keeping a Buy rating, citing alignment with fourth-quarter 2025 results and management's reiterated 2026 revenue guidance. The firm highlighted the ramp of iDose, the expansion pathway for Epioxa, and what it sees as ample liquidity to support commercialization. Other firms have als…
Palo Alto Networks shares dropped about 6% in pre-market trading after the company trimmed its 2026 adjusted earnings-per-share outlook, citing increased integration costs tied to recent acquisitions including CyberArk. While revenue guidance was raised, analysts note near-term margin pressure even as the company pursues a platform approach centere…
Brazil's central bank ordered the extrajudicial liquidation of Banco Pleno after determining the lender's economic and financial condition had weakened and it failed to meet regulatory requirements. The bank, controlled by Augusto Lima, was previously approved for acquisition last year and is linked to the earlier winding down of Banco Master. The …
Pinterest has revised its first-quarter guidance to account for the partial-quarter contribution from newly acquired tvScientific. The company narrowed and lowered its adjusted EBITDA range to $163 million-$183 million and raised revenue expectations to $958 million-$978 million. The acquisition closed on February 17 and is now reflected in Pintere…
Moderna shares rose following the U.S. Food and Drug Administration's decision to accept for review the company's biologics license application for its investigational seasonal influenza vaccine, mRNA-1010. The move follows a Type A meeting and a revised regulatory approach that seeks different approval pathways by age group, with a PDUFA goal date…
U.S. stock futures rose Wednesday as investors parsed a fresh wave of corporate earnings and awaited the minutes from the Federal Reserve's most recent policy meeting. Several high-profile movers stood out in pre-market trading, including gains for Nvidia, Amazon and The New York Times, and a notable drop for Palo Alto Networks after the cybersecur…
Needham has reaffirmed a Buy rating and a $45 price target on AtriCure Inc. following the company’s fourth-quarter 2025 results. While revenue matched the company preannouncement, adjusted EBITDA and earnings per share beat consensus estimates. Management reiterated 2026 revenue and adjusted EBITDA guidance and provided EPS guidance above consensus…
Upwork Inc. shares rose 6% Wednesday following the approval of a new $300 million share repurchase program. The board's action follows $136 million deployed to repurchase over 9 million shares in 2025 and brings total repurchase commitments to $600 million since November 2023. Management says the company will continue investing in SMB, AI and Enter…
Riot Platforms shares climbed 5% after Starboard Value sent a letter urging the company to accelerate deal-making for artificial intelligence and high-performance computing (AI/HPC) data centers. Starboard pointed to Riot’s 1.7 gigawatts of fully available power at Corsicana and Rockdale, praised the AMD arrangement as a positive but limited proof …
Par Pacific owns refining and logistics assets with high barriers to entry in Hawaii and the western U.S. At $43.04 the stock is trading at roughly 5.8x EV/EBITDA and a P/E around 9, leaving room for multiple expansion if refinery throughput and retail volumes remain strong. This trade idea outlines a mid-term swing setup with precise entry, stop a…
An analysis by WarrenAI identifies three enterprise software firms—Workday, Intuit and Salesforce—as leading candidates to convert AI adoption into outsized earnings growth. Each company is integrating AI into its core product suites, and analyst projections cited by the analysis show large prospective EPS gains and substantial upside to current sh…
Mizuho reaffirmed its Outperform rating and $51 price objective on Devon Energy (DVN), pointing to stronger capital efficiency in 2025, free cash flow that exceeded expectations, and ongoing cost-savings initiatives. The firm highlighted recent financial beats, a healthy free cash flow yield, and progress on a $1 billion Business Optimization Plan …
Oppenheimer increased its price target on Itron Inc. (NASDAQ: ITRI) to $133 from $125 and kept an Outperform rating after the company reported fourth-quarter 2025 results that beat consensus on both revenue and earnings and delivered fiscal 2026 guidance above market expectations. Itron also hit fiscal 2027 margin and free cash flow conversion targ…
Uber said it will invest over $100 million to create dedicated charging infrastructure for autonomous vehicles, installing DC fast chargers at its autonomous depots and pit stops in priority cities. The expansion begins in U.S. markets and includes utilization guarantee agreements with global chargepoint operators to support the rollout of hundreds…
Jefferies upgraded BioAge Labs Inc to Buy from Hold and raised its price target to $62 from $9, highlighting the promise of BGE-102, an oral NLRP3 inhibitor. The firm pointed to Phase 1 results and an attractive balance sheet as reasons for the upgrade. BioAge has public offerings planned to bolster its cash position as it advances Phase 2a and oph…
BofA Securities has resumed coverage of Kenvue Inc (NYSE: KVUE) but issued no rating, citing the pending acquisition by Kimberly-Clark. The consumer health company reported modest organic sales growth and margin resilience, while missing quarterly revenue and adjusted EPS expectations. Market valuation and recent stock performance reflect takeover …
Morgan Stanley’s review of fourth-quarter 13F filings finds mega-cap technology stocks are unusually under-owned versus the S&P 500, with Nvidia showing the largest shortfall in active institutional ownership. The bank highlights a tilt by institutions toward semiconductor and hardware names and comparatively light positioning in major software fir…
Oppenheimer downgraded AtriCure from Outperform to Perform and eliminated its $44 price target, pointing to secular weakness and increasing competitive pressure in the left atrial appendage closure market. The move follows AtriCure’s fourth-quarter 2025 results that matched company guidance and slightly beat consensus, but the firm remains unprofit…
MYX has closed a strategic financing round led by Consensys, with Systemic Ventures and Consensys’s VC arm participating. The capital will support research and development of MYX’s execution and risk systems, its chain abstraction framework, and the deployment of MYX V2, which promises one-click, gasless trades, more predictable pricing, and an inf…
U.S. markets reopened after a long weekend amid renewed volatility tied to artificial intelligence spending concerns, with the S&P 500 ending little changed while software stocks slumped and the VIX spiked toward some of its highest levels of the year. In Europe attention focused on reports that European Central Bank President Christine Lagarde is …
JPMorgan has reduced its rating on LuxExperience (NYSE:LUXE) to Neutral from Overweight and trimmed its price target to $10 from $14 following a correction to the company’s fully diluted share count. The change materially expands the share base and, by JPMorgan’s prior valuation logic, creates roughly a $5 per share headwind. The bank’s revised Dec…
UBS initiated coverage of Kratos Defense & Security Solutions (KTOS) with a Neutral rating and a $79 price target. The firm’s model anticipates revenue doubling and EBITDA tripling by 2030, but UBS warned that Kratos' current valuation - including an 86X next-12-months EV/EBITDA multiple - is materially stretched versus historical norms and peers. …
Barclays upgraded Molten Ventures from "equal weight" to "overweight" while maintaining a 575 pence price target, pointing to recent share-price weakness, an Investor Day that highlighted portfolio momentum, and a series of valuation recoveries led by several large holdings that together account for roughly 30% of net asset value (NAV).
JPMorgan moved Japan Airport Terminal Co., Ltd. from Overweight to Neutral and increased its price target to JPY6,000 from JPY5,200, saying the stock now offers limited upside. The share price has been supported by solid third-quarter results, a weaker yen and expectations for the next medium-term plan, while metrics such as a near-65% gross profit…
Cal-Maine (CALM) trades at rock-bottom multiples, generates meaningful free cash flow, and is expanding prepared-food capacity. The setup favors a swing trade: buy into current weakness, target a re-rating as specialty and prepared-food growth offsets commodity headwinds, and protect capital with a conservative stop.
